4.07 +0.20 (5.15%)
BCRX
| Trade BCRX now with |
|
Stock Details
Last Trade:4.07 Change:+0.20 (5.15%) Prev Close:3.87 Open: 3.88 Days Range:3.82 – 4.09 52 Week Range: 2.28 - 4.49 Volume:206145 P/E: N/AEPS:-0.76
View AllRecent Alerts 02/09/12
Recent Alert on 01/23/12 at 11:05am
Swine Flu Stocks Ramp Up (NVAX) (BCRX)
Swine Flu Stocks Ramp Up (NVAX) (BCRX)
Swine flu stocks are seeing some upside following report the death toll in Mexico reached nine and cases almost doubled. Novavax, Inc. (Nasdaq: NVAX) (+13%), BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) (+14%).
Recent Alert on 01/09/12 at 7:26am
BioCryst Pharma (BCRX) Reports Encouraging Results from BCX4208 Phase 2b
BioCryst Pharma (BCRX) Reports Encouraging Results from BCX4208 Phase 2b
Recent Alert on 01/09/12 at 7:26am
BioCryst Pharma (BCRX) Reports Encouraging Results from BCX4208 Phase 2b
BioCryst Pharma (BCRX) Reports Encouraging Results from BCX4208 Phase 2b
View AllRecent Press Releases
Press Release on 02/06/12 at 6:45am
BioCryst to Announce Fourth Quarter and Full Year 2011 Financial Results on February 16, 2012
BioCryst to Announce Fourth Quarter and Full Year 2011 Financial Results on February 16, 2012
View AllRecent SEC Filings
No Recent SEC Filings Available
View AllRecent Blog Posts
Blog Posts on 12/07/11 at 3:44pm
Savient's Krystexxa: How I Get A $209 Million Sales Estimate By 2015
Savient's Krystexxa: How I Get A $209 Million Sales Estimate By 2015
Blog Posts on 12/02/11 at 1:39pm
Savient Pharmaceuticals: The Potential Role Of Krystexxa The Treatment Of Gout
Savient Pharmaceuticals: The Potential Role Of Krystexxa The Treatment Of Gout